rs148575246

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 4P and 12B. PP3_StrongBP6_Very_StrongBS2

The ENST00000483582.5(IL17RC):​c.1478G>C​(p.Gly493Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0107 in 1,573,836 control chromosomes in the GnomAD database, including 118 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0075 ( 5 hom., cov: 33)
Exomes 𝑓: 0.011 ( 113 hom. )

Consequence

IL17RC
ENST00000483582.5 missense

Scores

1
3
3
Splicing: ADA: 1.000
2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 1.10

Publications

8 publications found
Variant links:
Genes affected
IL17RC (HGNC:18358): (interleukin 17 receptor C) This gene encodes a single-pass type I membrane protein that shares similarity with the interleukin-17 receptor (IL-17RA). Unlike IL-17RA, which is predominantly expressed in hemopoietic cells, and binds with high affinity to only IL-17A, this protein is expressed in nonhemopoietic tissues, and binds both IL-17A and IL-17F with similar affinities. The proinflammatory cytokines, IL-17A and IL-17F, have been implicated in the progression of inflammatory and autoimmune diseases. Multiple alternatively spliced transcript variants encoding different isoforms have been detected for this gene, and it has been proposed that soluble, secreted proteins lacking transmembrane and intracellular domains may function as extracellular antagonists to cytokine signaling. [provided by RefSeq, Feb 2011]
IL17RC Gene-Disease associations (from GenCC):
  • chronic mucocutaneous candidiasis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • candidiasis, familial, 9
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

PP3
Splicing predictors support a deleterious effect. Scorers claiming Pathogenic: dbscSNV1_ADA, dbscSNV1_RF, max_spliceai. No scorers claiming Uncertain. No scorers claiming Benign.
BP6
Variant 3-9932859-G-C is Benign according to our data. Variant chr3-9932859-G-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 542537.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 1141 Unknown,AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IL17RCNM_153460.4 linkc.1522+1G>C splice_donor_variant, intron_variant Intron 18 of 18 ENST00000403601.8 NP_703190.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IL17RCENST00000403601.8 linkc.1522+1G>C splice_donor_variant, intron_variant Intron 18 of 18 1 NM_153460.4 ENSP00000384969.3
ENSG00000288550ENST00000683484.1 linkn.1399+156G>C intron_variant Intron 16 of 23 ENSP00000507040.1

Frequencies

GnomAD3 genomes
AF:
0.00750
AC:
1142
AN:
152232
Hom.:
5
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00198
Gnomad AMI
AF:
0.00877
Gnomad AMR
AF:
0.00772
Gnomad ASJ
AF:
0.00173
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00186
Gnomad FIN
AF:
0.00471
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0126
Gnomad OTH
AF:
0.00621
GnomAD2 exomes
AF:
0.00630
AC:
1285
AN:
204104
AF XY:
0.00625
show subpopulations
Gnomad AFR exome
AF:
0.00168
Gnomad AMR exome
AF:
0.00437
Gnomad ASJ exome
AF:
0.00159
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00460
Gnomad NFE exome
AF:
0.0102
Gnomad OTH exome
AF:
0.0107
GnomAD4 exome
AF:
0.0111
AC:
15768
AN:
1421486
Hom.:
113
Cov.:
33
AF XY:
0.0108
AC XY:
7590
AN XY:
705180
show subpopulations
African (AFR)
AF:
0.00211
AC:
67
AN:
31782
American (AMR)
AF:
0.00450
AC:
165
AN:
36672
Ashkenazi Jewish (ASJ)
AF:
0.00187
AC:
43
AN:
22966
East Asian (EAS)
AF:
0.0000253
AC:
1
AN:
39530
South Asian (SAS)
AF:
0.00190
AC:
151
AN:
79404
European-Finnish (FIN)
AF:
0.00463
AC:
235
AN:
50810
Middle Eastern (MID)
AF:
0.00216
AC:
12
AN:
5558
European-Non Finnish (NFE)
AF:
0.0132
AC:
14487
AN:
1096290
Other (OTH)
AF:
0.0104
AC:
607
AN:
58474
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
894
1788
2682
3576
4470
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
566
1132
1698
2264
2830
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00749
AC:
1141
AN:
152350
Hom.:
5
Cov.:
33
AF XY:
0.00656
AC XY:
489
AN XY:
74502
show subpopulations
African (AFR)
AF:
0.00197
AC:
82
AN:
41586
American (AMR)
AF:
0.00771
AC:
118
AN:
15312
Ashkenazi Jewish (ASJ)
AF:
0.00173
AC:
6
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.00186
AC:
9
AN:
4828
European-Finnish (FIN)
AF:
0.00471
AC:
50
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0126
AC:
855
AN:
68028
Other (OTH)
AF:
0.00614
AC:
13
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
65
131
196
262
327
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00724
Hom.:
0
Bravo
AF:
0.00713
TwinsUK
AF:
0.00944
AC:
35
ALSPAC
AF:
0.0138
AC:
53
ESP6500AA
AF:
0.00300
AC:
12
ESP6500EA
AF:
0.00756
AC:
62
ExAC
AF:
0.00573
AC:
689
Asia WGS
AF:
0.00173
AC:
6
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Candidiasis, familial, 9 Benign:3
Jan 31, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 12, 2022
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 06, 2020
Al Jalila Children’s Genomics Center, Al Jalila Childrens Speciality Hospital
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

IL17RC-related disorder Benign:1
Jul 03, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

not provided Benign:1
Dec 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

IL17RC: BS1, BS2 -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.11
T
BayesDel_noAF
Uncertain
0.080
CADD
Pathogenic
26
DANN
Uncertain
0.99
Eigen
Pathogenic
0.84
Eigen_PC
Uncertain
0.64
FATHMM_MKL
Benign
0.63
D
PhyloP100
1.1
GERP RS
4.7
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Mutation Taster
=89/11
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
1.0
dbscSNV1_RF
Pathogenic
0.93
SpliceAI score (max)
0.97
Details are displayed if max score is > 0.2
DS_DL_spliceai
0.97
Position offset: -1

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs148575246; hg19: chr3-9974543; API